Are biological sensors modulated by their structural scaffolds? The role of the structural muscle proteins α-actinin-2 and α-actinin-3 as modulators of biological sensors

FEBS Letters

Volumn 584, Issue 14, 2010, Pages 2974-2980

  Lek, Monkol ^a,b   North, Kathryn N ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b University of Sydney   (Australia)

Author keywords

Actinin; Biological sensor; Skeletal muscle; Structural scaffold

Indexed keywords

ALPHA ACTININ 2; ALPHA ACTININ 3; CALCIUM ION; CALMODULIN; SCAFFOLD PROTEIN; VOLTAGE GATED POTASSIUM CHANNEL; ACTININ; MUSCLE PROTEIN; PROTEIN;

BIOSENSOR; CELL MEMBRANE; COMPLEX FORMATION; CONGESTIVE CARDIOMYOPATHY; GENETIC POLYMORPHISM; GLUCONEOGENESIS; GLYCOLYSIS; HUMAN; MUSCLE ATROPHY; MUSCLE CONTRACTION; MUSCLE DISEASE; MUSCLE FUNCTION; MUSCLE METABOLISM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN TRANSPORT; REVIEW; SKELETAL MUSCLE; UPREGULATION; GENETICS; METABOLISM; MUSCLE; PHYSIOLOGY;

ACTININ; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCLES; POLYMORPHISM, GENETIC; PROTEINS;

EID: 77954177590     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.05.059     Document Type: Review

References (87)

1. MacArthur D.G., North K.N. A gene for speed? The evolution and function of alpha-actinin-3. BioEssays 2004, 26:786-795.
2. Beggs A.H., Byers T.J., Knoll J.H., Boyce F.M., Bruns G.A., Kunkel L.M. Cloning and characterization of two human skeletal muscle alpha-actinin genes located on chromosomes 1 and 11. J. Biol. Chem. 1992, 267:9281-9288.
3. Mills M., Yang N., Weinberger R., Vander Woude D.L., Beggs A.H., Easteal S., North K. Differential expression of the actin-binding proteins, alpha-actinin-2 and -3, in different species: implications for the evolution of functional redundancy. Hum. Mol. Genet. 2001, 10:1335-1346.
4. MacArthur D.G., et al. Loss of ACTN3 gene function alters mouse muscle metabolism and shows evidence of positive selection in humans. Nat. Genet. 2007, 39:1261-1265.
5. Yang N., Garton F., North K. Alpha-actinin-3 and performance. Med. Sport Sci. 2009, 54:88-101.
6. Yang N., MacArthur D.G., Gulbin J.P., Hahn A.G., Beggs A.H., Easteal S., North K. ACTN3 genotype is associated with human elite athletic performance. Am. J. Hum. Genet. 2003, 73:627-631.
7. Clarkson P.M., et al. ACTN3 genotype is associated with increases in muscle strength in response to resistance training in women. J. Appl. Physiol. 2005, 99:154-163.
8. Moran C.N., et al. Association analysis of the ACTN3 R577X polymorphism and complex quantitative body composition and performance phenotypes in adolescent Greeks. Eur. J. Hum. Genet. 2007, 15:88-93.
9. Yngvadottir B., et al. A genome-wide survey of the prevalence and evolutionary forces acting on human nonsense SNPs. Am. J. Hum. Genet. 2009, 84:224-234.
10. MacArthur D.G., et al. An Actn3 knockout mouse provides mechanistic insights into the association between alpha-actinin-3 deficiency and human athletic performance. Hum. Mol. Genet. 2008, 17:1076-1086.
11. Chan S., Seto J.T., MacArthur D.G., Yang N., North K.N., Head S.I. A gene for speed: contractile properties of isolated whole EDL muscle from an alpha-actinin-3 knockout mouse. Am. J. Physiol. Cell Physiol. 2008, 295:C897-C904.
12. Parker G.E., Pederson B.A., Obayashi M., Schroeder J.M., Harris R.A., Roach P.J. Gene expression profiling of mice with genetically modified muscle glycogen content. Biochem J. 2006, 395:137-145.
13. Hansson O., Donsmark M., Ling C., Nevsten P., Danfelter M., Andersen J.L., Galbo H., Holm C. Transcriptome and proteome analysis of soleus muscle of hormone-sensitive lipase-null mice. J. Lipid Res. 2005, 46:2614-2623.
14. Garcia M., et al. Phosphofructo-1-kinase deficiency leads to a severe cardiac and hematological disorder in addition to skeletal muscle glycogenosis. PLoS Genet. 2009, 5:e1000615.
15. Milner D.J., Weitzer G., Tran D., Bradley A., Capetanaki Y. Disruption of muscle architecture and myocardial degeneration in mice lacking desmin. J. Cell Biol. 1996, 134:1255-1270.
16. Moza M., Mologni L., Trokovic R., Faulkner G., Partanen J., Carpen O. Targeted deletion of the muscular dystrophy gene myotilin does not perturb muscle structure or function in mice. Mol. Cell Biol. 2007, 27:244-252.
17. Brady J.P., Garland D.L., Green D.E., Tamm E.R., Giblin F.J., Wawrousek E.F. AlphaB-crystallin in lens development and muscle integrity: a gene knockout approach. Invest. Ophthalmol. Vis. Sci. 2001, 42:2924-2934.
18. Acakpo-Satchivi L.J., et al. Growth and muscle defects in mice lacking adult myosin heavy chain genes. J. Cell Biol. 1997, 139:1219-1229.
19. Chin D., Means A.R. Calmodulin: a prototypical calcium sensor. Trends Cell Biol. 2000, 10:322-328.
20. Tombola F., Pathak M.M., Isacoff E.Y. How does voltage open an ion channel?. Annu. Rev. Cell Dev. Biol. 2006, 22:23-52.
21. Epstein N.D., Davis J.S. Sensing stretch is fundamental. Cell 2003, 112:147-150.
22. Otey C.A., Carpen O. Alpha-actinin revisited: a fresh look at an old player. Cell Motil. Cytoskeleton 2004, 58:104-111.
23. Sjoblom B., Salmazo A., Djinovic-Carugo K. Alpha-actinin structure and regulation. Cell. Mol. Life Sci. 2008, 65:2688-2701.
24. Noegel A., Witke W., Schleicher M. Calcium-sensitive non-muscle alpha-actinin contains EF-hand structures and highly conserved regions. FEBS Lett. 1987, 221:391-396.
25. Fukami K., Furuhashi K., Inagaki M., Endo T., Hatano S., Takenawa T. Requirement of phosphatidylinositol 4, 5-bisphosphate for alpha-actinin function. Nature 1992, 359:150-152.
26. Lek M., Quinlan K.G., North K.N. The evolution of skeletal muscle performance: gene duplication and divergence of human sarcomeric alpha-actinins. BioEssays 2010, 32:17-25.
27. Lek M., MacArthur D.G., Yang N., North K.N. Phylogenetic analysis of gene structure and alternative splicing in alpha-actinins. Mol. Biol. Evol. 2010, 27:773-780.
28. Mohapatra B., et al. Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis. Mol. Genet. Metab. 2003, 80:207-215.
29. Gehmlich K., Geier C., Osterziel K.J., Van der Ven P.F., Furst D.O. Decreased interactions of mutant muscle LIM protein (MLP) with N-RAP and alpha-actinin and their implication for hypertrophic cardiomyopathy. Cell Tissue Res. 2004, 317:129-136.
30. Itoh-Satoh M., et al. Titin mutations as the molecular basis for dilated cardiomyopathy. Biochem. Biophys. Res. Commun. 2002, 291:385-393.
31. Burgueno J., et al. The adenosine A2A receptor interacts with the actin-binding protein alpha-actinin. J. Biol. Chem. 2003, 278:37545-37552.
32. Dobbins G.C., Luo S., Yang Z., Xiong W.C., Mei L. Alpha-actinin interacts with rapsyn in agrin-stimulated AChR clustering. Mol. Brain 2008, 1:18.
33. Maruoka N.D., Steele D.F., Au B.P., Dan P., Zhang X., Moore E.D., Fedida D. Alpha-actinin-2 couples to cardiac Kv1.5 channels, regulating current density and channel localization in HEK cells. FEBS Lett. 2000, 473:188-194.
34. Ziane R., Huang H., Moghadaszadeh B., Beggs A.H., Levesque G., Chahine M. Cell membrane expression of cardiac sodium channel Na(v)1.5 is modulated by alpha-actinin-2 interaction. Biochemistry 2010, 49:166-178.
35. Li Q., et al. Alpha-actinin associates with polycystin-2 and regulates its channel activity. Hum. Mol. Genet. 2005, 14:1587-1603.
36. Li Q., et al. Direct binding of alpha-actinin enhances TRPP3 channel activity. J. Neurochem. 2007, 103:2391-2400.
37. Sadeghi A., Doyle A.D., Johnson B.D. Regulation of the cardiac L-type Ca2+ channel by the actin-binding proteins alpha-actinin and dystrophin. Am. J. Physiol. Cell Physiol. 2002, 282:C1502-C1511.
38. Talior-Volodarsky I., Randhawa V.K., Zaid H., Klip A. Alpha-actinin-4 is selectively required for insulin-induced GLUT4 translocation. J. Biol. Chem. 2008, 283:25115-25123.
39. Nuriya M., Oh S., Huganir R.L. Phosphorylation-dependent interactions of alpha-actinin-1/IQGAP1 with the AMPA receptor subunit GluR4. J. Neurochem. 2005, 95:544-552.
40. Lu L., Zhang Q., Timofeyev V., Zhang Z., Young J.N., Shin H.S., Knowlton A.A., Chiamvimonvat N. Molecular coupling of a Ca2+-activated K+ channel to L-type Ca2+ channels via alpha-actinin2. Circ. Res. 2007, 100:112-120.
41. Hance J.E., Fu S.Y., Watkins S.C., Beggs A.H., Michalak M. Alpha-actinin-2 is a new component of the dystrophin-glycoprotein complex. Arch. Biochem. Biophys. 1999, 365:216-222.
42. Wyszynski M., Lin J., Rao A., Nigh E., Beggs A.H., Craig A.M., Sheng M. Competitive binding of alpha-actinin and calmodulin to the NMDA receptor. Nature 1997, 385:439-442.
43. Knoll R., et al. The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 2002, 111:943-955.
44. Geier C., et al. Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy. Hum. Mol. Genet. 2008, 17:2753-2765.
45. Boateng S.Y., Senyo S.E., Qi L., Goldspink P.H., Russell B. Myocyte remodeling in response to hypertrophic stimuli requires nucleocytoplasmic shuttling of muscle LIM protein. J. Mol. Cell. Cardiol. 2009, 47:426-435.
46. Pomies P., Louis H.A., Beckerle M.C. CRP1, a LIM domain protein implicated in muscle differentiation, interacts with alpha-actinin. J. Cell Biol. 1997, 139:157-168.
47. Arber S., et al. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell 1997, 88:393-403.
48. Arber S., Halder G., Caroni P. Muscle LIM protein, a novel essential regulator of myogenesis, promotes myogenic differentiation. Cell 1994, 79:221-231.
49. Chiu C., et al. Mutations in alpha-actinin-2 cause hypertrophic cardiomyopathy: a genome-wide analysis. J. Am. Coll. Cardiol. 2010, 55:1127-1135.
50. Hughes S.M., Chi M.M., Lowry O.H., Gundersen K. Myogenin induces a shift of enzyme activity from glycolytic to oxidative metabolism in muscles of transgenic mice. J. Cell Biol. 1999, 145:633-642.
51. Cheng H., Lederer W.J. Calcium sparks. Physiol. Rev. 2008, 88:1491-1545.
52. Olson E.N., Williams R.S. Remodeling muscles with calcineurin. BioEssays 2000, 22:510-519.
53. Frey N., Olson E.N. Calsarcin-3, a novel skeletal muscle-specific member of the calsarcin family, interacts with multiple Z-disc proteins. J. Biol. Chem. 2002, 277:13998-14004.
54. Faulkner G., et al. FATZ, a filamin-, actinin-, and telethonin-binding protein of the Z-disc of skeletal muscle. J. Biol. Chem. 2000, 275:41234-41242.
55. Takada F., Vander Woude D.L., Tong H.Q., Thompson T.G., Watkins S.C., Kunkel L.M., Beggs A.H. Myozenin: an alpha-actinin- and gamma-filamin-binding protein of skeletal muscle Z lines. Proc. Natl. Acad. Sci. USA 2001, 98:1595-1600.
56. Frey N., Richardson J.A., Olson E.N. Calsarcins, a novel family of sarcomeric calcineurin-binding proteins. Proc. Natl. Acad. Sci. USA 2000, 97:14632-14637.
57. Frey N., et al. Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress. Nat. Med. 2004, 10:1336-1343.
58. Frey N., et al. Calsarcin-2 deficiency increases exercise capacity in mice through calcineurin/NFAT activation. J. Clin. Invest. 2008, 118:3598-3608.
59. von Nandelstadh P., et al. A class III PDZ binding motif in the myotilin and FATZ families binds enigma family proteins: a common link for Z-disc myopathies. Mol. Cell Biol. 2009, 29:822-834.
60. Sandri M., et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004, 117:399-412.
61. Bodine S.C., et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001, 294:1704-1708.
62. Li H.H., Kedar V., Zhang C., McDonough H., Arya R., Wang D.Z., Patterson C. Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J. Clin. Invest. 2004, 114:1058-1071.
63. Tintignac L.A., Lagirand J., Batonnet S., Sirri V., Leibovitch M.P., Leibovitch S.A. Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase. J. Biol. Chem. 2005, 280:2847-2856.
64. Jogo M., Shiraishi S., Tamura T.A. Identification of MAFbx as a myogenin-engaged F-box protein in SCF ubiquitin ligase. FEBS Lett. 2009, 583:2715-2719.
65. Masters C. Interactions between glycolytic enzymes and components of the cytomatrix. J. Cell Biol. 1984, 99:222s-225s.
66. Kraft T., Hornemann T., Stolz M., Nier V., Wallimann T. Coupling of creatine kinase to glycolytic enzymes at the sarcomeric I-band of skeletal muscle: a biochemical study in situ. J. Muscle Res. Cell Motil. 2000, 21:691-703.
67. Rakus D., Mamczur P., Gizak A., Dus D., Dzugaj A. Colocalization of muscle FBPase and muscle aldolase on both sides of the Z-line. Biochem. Biophys. Res. Commun. 2003, 311:294-299.
68. Chowrashi P., Mittal B., Sanger J.M., Sanger J.W. Amorphin is phosphorylase; phosphorylase is an alpha-actinin-binding protein. Cell Motil. Cytoskeleton 2002, 53:125-135.
69. Lane R.D., Hegazy M.G., Reimann E.M. Subcellular localization of glycogen synthase with monoclonal antibodies. Biochem. Int. 1989, 18:961-970.
70. Mamczur P., Rakus D., Gizak A., Dus D., Dzugaj A. The effect of calcium ions on subcellular localization of aldolase-FBPase complex in skeletal muscle. FEBS Lett. 2005, 579:1607-1612.
71. Rakus D., Pasek M., Krotkiewski H., Dzugaj A. Muscle FBPase in a complex with muscle aldolase is insensitive to AMP inhibition. FEBS Lett. 2003, 547:11-14.
72. Rakus D., Pasek M., Krotkiewski H., Dzugaj A. Interaction between muscle aldolase and muscle fructose 1,6-bisphosphatase results in the substrate channeling. Biochemistry 2004, 43:14948-14957.
73. Mamczur P., Dus D., Dzugaj A. Colocalization of aldolase and FBPase in cytoplasm and nucleus of cardiomyocytes. Cell Biol. Int. 2007, 31:1122-1130.
74. Gizak A., Wrobel E., Moraczewski J., Dzugaj A. Changes in subcellular localization of fructose 1,6-bisphosphatase during differentiation of isolated muscle satellite cells. FEBS Lett. 2006, 580:4042-4046.
75. Gizak A., Rakus D., Dzugaj A. Nuclear localization of fructose 1,6-bisphosphatase in smooth muscle cells. J. Mol. Histol. 2005, 36:243-248.
76. Gizak A., Maciaszczyk-Dziubinska E., Jurowicz M., Rakus D. Muscle FBPase is targeted to nucleus by its 203KKKGK207 sequence. Proteins 2009, 77:262-267.
77. Yanez A.J., Garcia-Rocha M., Bertinat R., Droppelmann C., Concha I.I., Guinovart J.J., Slebe J.C. Subcellular localization of liver FBPase is modulated by metabolic conditions. FEBS Lett. 2004, 577:154-158.
78. McLane J.A., Holloszy J.O. Glycogen synthesis from lactate in the three types of skeletal muscle. J. Biol. Chem. 1979, 254:6548-6553.
79. Gizak A., Maciaszczyk E., Dzugaj A., Eschrich K., Rakus D. Evolutionary conserved N-terminal region of human muscle fructose 1,6-bisphosphatase regulates its activity and the interaction with aldolase. Proteins 2008, 72:209-216.
80. Hakimi P., et al. Overexpression of the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) in skeletal muscle repatterns energy metabolism in the mouse. J. Biol. Chem. 2007, 282:32844-32855.
81. Faul C., Dhume A., Schecter A.D., Mundel P. Protein kinase A, Ca2+/calmodulin-dependent kinase II, and calcineurin regulate the intracellular trafficking of myopodin between the Z-disc and the nucleus of cardiac myocytes. Mol. Cell Biol. 2007, 27:8215-8227.
82. Coghill I.D., Brown S., Cottle D.L., McGrath M.J., Robinson P.A., Nandurkar H.H., Dyson J.M., Mitchell C.A. FHL3 is an actin-binding protein that regulates alpha-actinin-mediated actin bundling: FHL3 localizes to actin stress fibers and enhances cell spreading and stress fiber disassembly. J. Biol. Chem. 2003, 278:24139-24152.
83. Huang H.T., Brand O.M., Mathew M., Ignatiou C., Ewen E.P., McCalmon S.A., Naya F.J. Myomaxin is a novel transcriptional target of MEF2A that encodes a Xin-related alpha-actinin-interacting protein. J. Biol. Chem. 2006, 281:39370-39379.
84. Durham J.T., Brand O.M., Arnold M., Reynolds J.G., Muthukumar L., Weiler H., Richardson J.A., Naya F.J. Myospryn is a direct transcriptional target for MEF2A that encodes a striated muscle, alpha-actinin-interacting, costamere-localized protein. J. Biol. Chem. 2006, 281:6841-6849.
85. Yu J.G., Carlsson L., Thornell L.E. Evidence for myofibril remodeling as opposed to myofibril damage in human muscles with DOMS: an ultrastructural and immunoelectron microscopic study. Histochem. Cell Biol. 2004, 121:219-227.
86. Deconinck A.E., et al. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 1997, 90:717-727.
87. Nowak K.J., et al. Rescue of skeletal muscle alpha-actin-null mice by cardiac (fetal) alpha-actin. J. Cell Biol. 2009, 185:903-915.